LAB vs TWLO · rev $174.4M vs P/E 1087, rev $4.46B
Standard Biotools Inc (LAB) versus Twilio Inc (TWLO) — a side-by-side from cached financials, not a winner call.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Twilio Inc (TWLO) is a software - infrastructure company listed on US.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
Latest reported TWLO revenue for 2024-12-31 was $4.46B. Net income was -$109.4M. Revenue was up 7.3% from 2023-12-31 to 2024-12-31. TWLO currently screens at market cap $16.67B and trailing P/E 1086.7.
LAB currently screens at market cap $317.1M. TWLO currently screens at market cap $16.67B and trailing P/E 1086.7.
Not investment advice. Open the LAB and TWLO stock pages for the full models.
Not investment advice.